Sign In
By signing in or creating an account, you agree with Associated Broadcasting Company's Terms & Conditions and Privacy Policy.
By signing in or creating an account, you agree with Associated Broadcasting Company's Terms & Conditions and Privacy Policy.
New Delhi: India's primary market may see a series of listings from the healthcare sector in 2026. According to investment bankers, IPOs worth about Rs 20,000 crore are set to enter the market. This includes large hospital groups and rapidly growing IVF chains. Due to strong business growth and good valuation, companies are showing speed in bringing IPOs.
Manipal Hospitals, the second largest hospital chain in the country, is all set to launch an IPO of around Rs 8,500—Rs 9,000 crore. This will be one of the biggest healthcare public offerings of 2026. South India's Cauvery Hospital also wants to raise more than Rs 1,500 crore for its expansion. In addition, Asia Healthcare Holdings is also preparing to hit the market. Similarly, Paras Hospitals, which filed its papers in 2024, is expected to knock the doors of SEBI in the upcoming year. Yashoda Hospital in Hyderabad has done confidential (confidential) filing of about Rs 4,000 crore.
Fast-growing IVF companies are also ready to enter the market. Indira IVF has confidentially re-filed in July 2025. Its issue is believed to be worth about Rs 3,500 crore. Bengaluru's Cloudnine is also planning to raise more than Rs 1,000 crore.
Why is the IPO trend towards the healthcare sector increasing?
In addition, due to the valuation of the public market being higher than the private market, companies want to benefit from the IPO. Many promoters are bringing in fresh capital to reduce debt, add new beds and expand, while private equity funds want partial exit (partial exit).
India still lags behind many countries in terms of healthcare-
India is becoming a big center of medical tourism. Five years ago, this industry was worth $6 billion, it is expected to double next year. Surgery prices in India are up to 10 times cheaper than in the US. For example-
Hip Replacement in the US: $50,000, while in India it costs around $7,000.
The demand for IVF is also increasing rapidly. 15% of couples in the country have infertility problems, but now only 25% of the market uses IVF services. So there is huge scope for growth for companies.
Data Source: ET, NSE
(Disclaimer: This article is only meant to provide information. TV9 does not recommend buying or selling shares or subscriptions of any IPO, Mutual Funds, gold, silver and crypto assets.)
